Elizabeth Gaffney, PA-C

• Educated Nephrology & Rheumatology practices on lupus nephritis/rare disease including community healthcare providers and those affiliated with UF/JAX and Mayo Clinic
• Promoted to Medical Science Liaison (MSL) 10/24
• Product: LUPKYNIS/voclosporin
• Launched rare disease molecule for lupus nephritis as well as start up company in South and Eastern Georgia and North Florida including east Orlando
• Capitalized on institutional sales experience and PA career to launch LUPKYNIS at UF Shands and JAX. Was 1/5 successful reps nationally to implement direct ship to hospital pharmacies
• Achieved company growth by implementing strategic marketing plans and business development initiatives.
• Expanded market presence by identifying new business opportunities and forging strategic partnerships.
• Managed cross-functional teams for successful project completion within budgetary constraints and deadlines.
• Spot award recipient for crossing boundaries and helping physician at Mayo Clinic Phoenix navigate access to LUPKYNIS 2022
• Exceeded business plan in patient starts 2022
• 2024 YTD rank 17/72-EXCEEDED EXPECTATIONS on year end review

Was promoted to MSL to foster strong relationships with academic institutions as well as lupus centers of excellence for LUPKYNIS. Increase study enrollment for AUR200 and establish relationships with KOLs. Expand on clinical knowledge, pharmacovigilance, regulatory compliance and data analysis. Due to reorganization, the department was dissolved. I was maintained in Commercial Ops.

• Target physicians include Nephrologist, Clinical Cardiologist, Interventional Cardiologist, Internal and Family Medicine Physicians
• Accounts- UF Health Shands Hospital-Gainesville and Jacksonville, FL, Baptist Medical-Jacksonville and surrounding areas, Putnam Community Medical Center Florida Hospital-Flagler, Flagler Hospital, Saint Augustine, St
• Vincent's Medical Centers-Jacksonville, MAYO Clinic Jacksonville, Memorial Hospital Jacksonville
• Product: Brilinta, Farxiga, Lokelma
• Evaluated therapy effectiveness using data-driven approaches, making necessary adjustments to optimize patient outcomes.
• Served as a liaison between patients, healthcare providers, and insurance companies, facilitating timely access to essential care services.
• Sales QTD attainment 107.61% (Quarter 2, 2018)
• Winner of the Brilinta 60 mg volume contest 3rd quarter 2018
• Increase sales of Brilinta and Farxiga across spectrum of medical practices
• Targeted thought leaders for P&T approval of Lokelma, research and educate Physicians and staff on hyperkalemia/CRD.
• Navigated territory for potential targets and early adapters for launch of Lokelma by conversing on disease state and getting clearer idea of their algorithms
• Launched Lokelma in hospitals and Nephrology, Cardiology and IM offices
• QTD (5/24/19) sales data; 103% to goal with Lokelma trialist

• Target physicians included Clinical Cardiologist, Interventional Cardiologist, Electrophysiologist, Cath Lab personnel, Nurses, Coordinators and Intensivist
• Accounts- Mount Sinai Medical Center-Miami, FL, Aventura Hospital, Aventura, FL Memorial Hospital System-Hollywood, FL
• Product: Ranexa
• Sales QTD attainment: 105.29% (May 2015)
• Regional Ranking Report May- 3/23
• YTD Rank June 2015 80/176
• YTD Rank September 2015 118/176

• Targets included, ER Physicians, Pain Management Physicians, Endocrinologists, OB/GYN's, PCP's, Rheumatologist, ENT's, Neurologist, Cardiologists, and Dermatologist
• Territories included South Palm Beach County, Broward County, Miami-Dade and Monroe County
• Products sold: Lantus Injectable, Apidra Injectable, Ambien CR, Allegra Family, Nasacort AQ, Actonel, Ketek, Avapro/Avalide, and Xyzal
• See above professional accomplishments

• Critical Care Certification; University of Miami/Jackson Memorial Hospital
• Managed complex cases involving multiple health issues, collaborating with specialists to develop effective treatment plans.
• Contributed to team-based approach in caring for patients by effectively coordinating with nurses, therapists, social workers, and other healthcare providers.
• Referred to and consulted with physicians and other healthcare providers on patient care.
• Provided services which included prescribing medication/orders and performing surgery on adult and pediatric Cardiothoracic and Vascular patients
• Trained and precepted medical students and PA students during surgical rotations
• Was influential in decisions regarding purchasing of endoscopic devices
• Was instrumental in starting robotic cardiac surgery at Memorial Regional Hospital
• Trainer for the Da Vinci Robot and traveled internationally to train Surgeons on operative technique, Venice, Italy
• Elected Chief PA and was in charge of on-call schedules and assigning cases to PAs, teaching critical care and surgical technique to students/interns/residents on rotation
• First-assisted in more than 1500 cases, harvested more than 800 saphenous veins and 50 radial arteries via endoscope and/or open technique
• In charge of post-op ICU patients which included decisions on care based on lab values physical exams, chest tube output, EKG readings, vent settings etc
• Educated patients on medication management, ensuring proper usage and adherence for optimal results.
• Collaborated with physicians to provide optimal patient care, ensuring accurate diagnoses and appropriate treatment plans.